| BLUE Snapshot | |
|---|---|
| bluebird bio, Inc., a biotechnology company, researches, develops and markets transformative gene therapies for serious genetic diseases and cancer. The company is headquartered in Cambridge, Massachusetts. | |
| VALUATION DATA | |
| Market Capitalization | $177,882,000 | Price to Sales | 7.00 |
| Earnings per Share | $-0.6300 |
| PE Ratio | None |
| PRICE DATA | |
| Most Recent Close | $0.9125 |
| 52 Week High | $9.76 |
| 52 Week Low | $0.961 |
| 50-Day Moving Average | $15.8 |
| 200-Day Moving Average | $-2.605 |
| All data are from Alpha Vantage as of today. For more infomation on BLUE see Stock Dividend, Valuation, Price and Financial Data for Investors | |
Custom Search